BC: Nathaniel Hawkins, Christina Luong
Please describe the research project and how it contributes to improving primary care
The MAPLE-CHF study is part of part of an international collaboration of five randomized controlled trials screening for heart failure using common study design elements and endpoints in five countries (Canada, Scotland, Sweden, Denmark, United States). In BC and Quebec, consenting community members with risk factors for heart failure are randomized to a strategy of active screening using NT-proBNP plus artificial intelligence echocardiography versus usual care.
The goal of MAPLE-CHF is to understand whether this early detection strategy in primary care clinics increases early heart failure diagnoses at 6 months compared with usual care.
How is BC-PHCRN involved?
The BC-PHCRN engages with provincial health authorities, primary care practices and community health centers to collaborate on research projects of interest. The Network is also involved in the Canadian Primary Care Research Network (soon to be Consortium) that works with practice-based research networks collectively serving >2.5 million patients across Canada. Engagement with health providers through these known networks not only supports project engagement but also invites health provider voices to inform study initiatives.
How will the results of this initiative be shared with partners (i.e. clinicians, policy makers, patients)?
The BC-PHCRN regularly meets with the BC Ministry of Health representatives where opportunities to share progress and connect with other provincial or national health organizations interested in the work will be sought after. Our Network will also share progress with our clinical and patient partner advisory committees, and through these collaborations determine how best to share with Network communities. This project is also part of a pan-Canadian initiative that will endeavor to share results through national, international publications and conferences.